Skip to content

Performance attributes and user progression while using Ekso Robotic Exoskeleton in an eight week, over ground, locomotor program in individuals with spinal cord injury

Performance attributes and user progression while using Ekso Robotic Exoskeleton in an eight week, over ground, locomotor program in individuals with spinal cord injury - Feasibility of an exoskeleton training in individuals with SCI

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON42049
Enrollment
8
Registered
2014-06-16
Start date
2015-01-12
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

paraplegia/tetraplegia spinal cord injury

Interventions

24 training sessions with an robotic exoskeleton device (Ekso exoskeleton) during an eight week training period.

Sponsors

Heliomare
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: People with motor complete or motor incomplete SCI who are participating in inpatient or outpatient rehabilitation

Exclusion criteria

Exclusion criteria: - Any medical issue that in the opinion of the Investigator precludes full weight bearing locomotor training. - Any medical issue that in the opinion of the Investigator would affect participant safety either due to cognitive deficits/impulsivity, intolerance to mild exercise or other factors. - Any issue that in the opinion of the Investigator would confound results such as a concurrent neurological injury or disorder (other than SCI) or other factors. - Skin integrity issues in areas that contact the device (including abdominal ostomies) or that would prohibit sitting. -Pregnancy.

Design outcomes

Primary

MeasureTime frame
Performance attributes and user progression in terms of ability to complete an eight week training program and time frame to achieve an increased level of independence in activities: * The number of Ekso sessions completed * Number of steps in device * Time spent walking in device * Number of training sessions in each mode * Change over time in terms of level of assistance from personnel, assistive device utilized, and locomotor ability while ambulating in the Ekso device

Secondary

MeasureTime frame
The following assessments will be completed to address secondary outcome parameters: * Cardiovascular impact * Perceived rate of exertion (PRE) * Bowel function * Bladder function * Quality of life * Functional abilities * Pain * Spasticity * Strength * Walking ability (if applicable) * Energy expenditure * Muscle activity

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)